{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T21:00:08Z","timestamp":1778101208526,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.ijantimicag.2019.10.009","type":"journal-article","created":{"date-parts":[[2019,10,26]],"date-time":"2019-10-26T17:38:26Z","timestamp":1572111506000},"page":"105828","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Antivirulence activity of auranofin against vancomycin-resistant enterococci: in vitro and in vivo studies"],"prefix":"10.1016","volume":"55","author":[{"given":"Nader S.","family":"Abutaleb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0939-0458","authenticated-orcid":false,"given":"Mohamed N.","family":"Seleem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2019.10.009_bib0001","doi-asserted-by":"crossref","first-page":"e00534","DOI":"10.1128\/mBio.00534-13","article-title":"Emergence of epidemic multidrug-resistant Enterococcus faecium from animal and commensal strains","volume":"4","author":"Lebreton","year":"2013","journal-title":"MBio"},{"key":"10.1016\/j.ijantimicag.2019.10.009_bib0002","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1128\/CMR.13.4.686","article-title":"Vancomycin-resistant enterococci","volume":"13","author":"Cetinkaya","year":"2000","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2019.10.009_bib0003","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.mib.2013.01.006","article-title":"Genomic transition of enterococci from gut commensals to leading causes of multidrug-resistant hospital infection in the antibiotic era","volume":"16","author":"Gilmore","year":"2013","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.10.009_bib0004","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1128\/CMR.13.4.513","article-title":"Relationships between enterococcal virulence and antimicrobial resistance","volume":"13","author":"Mundy","year":"2000","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2019.10.009_bib0005","article-title":"Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics","volume":"27","author":"Tacconelli","year":"2017","journal-title":"WHO"},{"key":"10.1016\/j.ijantimicag.2019.10.009_bib0006","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.2174\/1381612823666170209154745","article-title":"In Vitro Screening of an FDA-Approved Library Against ESKAPE Pathogens","volume":"23","author":"Younis","year":"2017","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.ijantimicag.2019.10.009_bib0007","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ijantimicag.2015.12.016","article-title":"Repurposing auranofin for the treatment of cutaneous staphylococcal infections","volume":"47","author":"Thangamani","year":"2016","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2019.10.009_bib0008","doi-asserted-by":"crossref","first-page":"750","DOI":"10.3389\/fmicb.2015.00750","article-title":"Repurposing celecoxib as a topical antimicrobial agent","volume":"6","author":"Thangamani","year":"2015","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.10.009_bib0009","doi-asserted-by":"crossref","first-page":"8353","DOI":"10.1038\/s41598-018-26674-0","article-title":"Repurposing auranofin as an intestinal decolonizing agent for vancomycin-resistant enterococci","volume":"8","author":"AbdelKhalek","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijantimicag.2019.10.009_bib0010","volume":"32","year":"2012"},{"key":"10.1016\/j.ijantimicag.2019.10.009_bib0011","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.bbagen.2017.01.029","article-title":"Targeting biofilms and persisters of ESKAPE pathogens with P14KanS, a kanamycin peptide conjugate","volume":"1861","author":"Mohamed","year":"2017","journal-title":"Bba-Gen Subjects"},{"key":"10.1016\/j.ijantimicag.2019.10.009_bib0012","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.1128\/AAC.01230-07","article-title":"Effects of antibiotics on quorum sensing in Pseudomonas aeruginosa","volume":"52","author":"Skindersoe","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.10.009_bib0013","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4103\/0974-777X.145242","article-title":"Virulence markers of vancomycin resistant enterococci isolated from infected and colonized patients","volume":"6","author":"Biswas","year":"2014","journal-title":"J Global Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.10.009_bib0014","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1365-2672.1974.tb00424.x","article-title":"The egg yolk reaction produced by several species of bacteria","volume":"37","author":"Owens","year":"1974","journal-title":"J Appl Bacteriol"},{"key":"10.1016\/j.ijantimicag.2019.10.009_bib0015","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2105\/AJPH.44.1.49","article-title":"Studies on bacterial hemagglutination","volume":"44","author":"Neter","year":"1954","journal-title":"Am J Public Health Nations Health"},{"key":"10.1016\/j.ijantimicag.2019.10.009_bib0016","first-page":"e1828","article-title":"Hemagglutination Inhibition (HI) Assay of Influenza Viruses with Monoclonal Antibodies","volume":"6","author":"Wu","year":"2016","journal-title":"Bio-protoc"},{"key":"10.1016\/j.ijantimicag.2019.10.009_bib0017","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1086\/314453","article-title":"Generation and testing of mutants of Enterococcus faecalis in a mouse peritonitis model","volume":"178","author":"Singh","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.10.009_bib0018","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1128\/iai.56.9.2369-2372.1988","article-title":"Use of lymphokines in treatment of experimental intra-abdominal abscess caused by Bacteroides fragilis","volume":"56","author":"Gollapudi","year":"1988","journal-title":"Infect Immun"},{"key":"10.1016\/j.ijantimicag.2019.10.009_bib0019","doi-asserted-by":"crossref","first-page":"4612","DOI":"10.1128\/AAC.02790-13","volume":"58","author":"Luther","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.10.009_bib0020","first-page":"e00424","article-title":"In vivo and in vitro effects of a ClpP-activating antibiotic against vancomycin-resistant enterococci","volume":"62","author":"Gandt","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.10.009_bib0021","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1128\/AAC.42.12.3251","article-title":"The oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria","volume":"42","author":"Swaney","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.10.009_bib0022","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF00295499","article-title":"Hemagglutination properties of Enterococcus","volume":"30","author":"Maria da Gl\u00f3ria","year":"1995","journal-title":"Curr Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.10.009_bib0023","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.1172\/JCI43918","article-title":"Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans","volume":"120","author":"Ubeda","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ijantimicag.2019.10.009_bib0024","series-title":"Antibiotic resistance threats in the United States, 2013","year":"2013"},{"key":"10.1016\/j.ijantimicag.2019.10.009_bib0025","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1469-0691.2010.03214.x","article-title":"Management of multidrug-resistant enterococcal infections","volume":"16","author":"Arias","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2019.10.009_bib0026","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.ijantimicag.2018.02.003","article-title":"Repurposing niclosamide for intestinal decolonization of vancomycin-resistant enterococci","volume":"51","author":"Mohammad","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2019.10.009_bib0027","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0199710","article-title":"Repurposing ebselen for decolonization of vancomycin-resistant enterococci (VRE)","volume":"13","author":"AbdelKhalek","year":"2018","journal-title":"PloS one"},{"key":"10.1016\/j.ijantimicag.2019.10.009_bib0028","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0732-8893(93)90100-L","article-title":"Susceptibility of beta-lactamase-producing enterococci to piperacillin with tazobactam","volume":"17","author":"Okhuysen","year":"1993","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.10.009_bib0029","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/j.1469-0691.1999.tb00434.x","article-title":"MIC distribution and inoculum effect of LY333328: a study of vancomycin-susceptible and VanA-type and VanC-type enterococci obtained from intensive care unit patient surveillance cultures","volume":"5","author":"Rafael Cant\u00f3n","year":"1999","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2019.10.009_bib0030","first-page":"22","article-title":"Synthesis, antiinflammatory and antiarthritic properties of a new tiopronine gold derivative","volume":"128","author":"Coppi","year":"1989","journal-title":"Boll Chim Farm"},{"key":"10.1016\/j.ijantimicag.2019.10.009_bib0031","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nature12790","article-title":"Activated ClpP kills persisters and eradicates a chronic biofilm infection","volume":"503","author":"Conlon","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ijantimicag.2019.10.009_bib0032","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2017.02000","article-title":"Molecular Basis of Stationary Phase Survival and Applications","volume":"8","author":"Jaishankar","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.10.009_bib0033","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/bcp.12356","article-title":"Targeting virulence not viability in the search for future antibacterials","volume":"79","author":"Heras","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ijantimicag.2019.10.009_bib0034","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s004380051090","article-title":"Interactive regulatory pathways control virulence determinant production and stability in response to environmental conditions in Staphylococcus aureus","volume":"262","author":"Lindsay","year":"1999","journal-title":"Mol Gen Genet"},{"key":"10.1016\/j.ijantimicag.2019.10.009_bib0035","first-page":"353","article-title":"Experimental Endocarditis in Rabbits: 3. Significance of the Proteolytic Capacity of the Infecting Strains of Streptococcus Faecalis","volume":"87","author":"Gutschik","year":"1979","journal-title":"Acta Pathol Microbiol Scand B"},{"key":"10.1016\/j.ijantimicag.2019.10.009_bib0036","article-title":"Host and bacterial proteases influence biofilm formation and virulence in a murine model of enterococcal catheterassociated urinary tract infection","volume":"28","author":"Wei Xu","year":"2017","journal-title":"NPJ"},{"key":"10.1016\/j.ijantimicag.2019.10.009_bib0037","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1099\/00221287-146-6-1419","article-title":"Identification of a second lipase gene, gehD, in Staphylococcus epidermidis: comparison of sequence with those of other staphylococcal lipases","volume":"146","author":"Longshaw","year":"2000","journal-title":"Microbiol-Uk"},{"key":"10.1016\/j.ijantimicag.2019.10.009_bib0038","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1381-1177(03)00049-3","article-title":"Microbial lipases as virulence factors","volume":"22","author":"Stehr","year":"2003","journal-title":"J Mol Catal B-Enzym"},{"key":"10.1016\/j.ijantimicag.2019.10.009_bib0039","doi-asserted-by":"crossref","first-page":"22571","DOI":"10.1038\/srep22571","article-title":"Antibacterial activity and mechanism of action of auranofin against multi-drug resistant bacterial pathogens","volume":"6","author":"Thangamani","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijantimicag.2019.10.009_bib0040","first-page":"5","article-title":"Hemagglutination properties of some intestinal bacterial pathogens isolated from clinical samples","volume":"15","author":"Shareef","year":"2010","journal-title":"Tikrit J Pure Sci"},{"key":"10.1016\/j.ijantimicag.2019.10.009_bib0041","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1306801","article-title":"Multistate point-prevalence survey of health care-associated infections","volume":"370","author":"Magill","year":"2014","journal-title":"New Eng J Med"},{"key":"10.1016\/j.ijantimicag.2019.10.009_bib0042","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1002\/art.1780310806","article-title":"The efficacy and safety of auranofin in the treatment of juvenile rheumatoid arthritis. A long-term open study","volume":"31","author":"Marcolongo","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ijantimicag.2019.10.009_bib0043","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/15027732.1986.12461442","article-title":"Long-term efficacy and safety of auranofin: a review of clinical experience","volume":"63","author":"Blodgett","year":"1986","journal-title":"Scand J Rheumatol Suppl"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857919302894?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857919302894?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:36:53Z","timestamp":1760377013000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857919302894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0924857919302894"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.10.009","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antivirulence activity of auranofin against vancomycin-resistant enterococci: in vitro and in vivo studies","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105828"}}